Calyxha Biotechnologies

Calyxha Biotechnologies is a biotech startup based in Austria that is focused on revolutionizing the treatment of inflammation. Established in 2019, the company's slogan "A new perspective on inflammation" encapsulates their mission to bring innovative solutions to the field. Specializing in the development of novel small molecule anti-inflammatory drugs, Calyxha has attracted the attention of investors. In February 2020, Calyxha successfully secured a notable €1.00M Seed Round investment from Arax Capital Partners and Kinled Holding. This funding signifies a strong vote of confidence from renowned investment entities in Calyxha's potential. With this injection of capital, Calyxha is well-positioned to accelerate its research and development efforts and advance toward bringing its breakthrough treatments to market. The company's ability to attract investment reflects the promising trajectory of their groundbreaking research and the potential impact of their innovations in the field of biotechnology. Calyxha Biotechnologies stands at the forefront of addressing a critical medical need, and their progress in securing funding underscores the industry's recognition of their vision and capabilities. As the company continues to advance its developments, its collaboration with respected investment partners provides a solid foundation for driving future success in the critical area of anti-inflammatory therapeutics.